News & Media
Newsroom
SK life science presents new data on its lead investigational compound, cenobamate, at the American Epilepsy Society 2018 Annual Meeting
12.3.2018
Full Release
SK life science honors Epilepsy Awareness Month with support for patients, advocates, caregivers, and healthcare providers
11.1.2018
Full Release
SK life science awards educational grant to J. Kiffin Penry Epilepsy Education Programs in support of neurology residents and epilepsy fellows
5.15.2018
Full Release
Welcome to the news and information center for SK Life Science, Inc.
To learn more about SK Life Science, please download our corporate brochure
For more information about epilepsy, please download this infographic
For more information about Lennox-Gastaut syndrome, please download this fact sheet
SK Life Science at a Glance
Headquarters Location: Paramus, NJ
R&D Begins: 1993
Parent Company: SK Life Science is a subsidiary of SK Biopharmaceuticals, CO., LTD, and both are a part of SK Group
Number of Employees: 200+ Employees
Disease Category Focus: CNS Disorders and Oncology
Pipeline: 8 compounds under clinical development